<--- Back to Details
First PageDocument Content
Food and Drug Administration / Prescription Drug User Fee Act / Pharmaceutical industry / Drug development / Clinical trial / Tomas J. Philipson / Trastuzumab / Criticism of the Food and Drug Administration / Expanded access / Pharmacology / Pharmaceutical sciences / Clinical research
Date: 2010-06-13 14:31:22
Food and Drug Administration
Prescription Drug User Fee Act
Pharmaceutical industry
Drug development
Clinical trial
Tomas J. Philipson
Trastuzumab
Criticism of the Food and Drug Administration
Expanded access
Pharmacology
Pharmaceutical sciences
Clinical research

Microsoft Word - Philipson PRESS RELEASE[removed]ph edits.doc

Add to Reading List

Source URL: www.manhattan-institute.org

Download Document from Source Website

File Size: 51,52 KB

Share Document on Facebook

Similar Documents

View Last Accessed Through Grade Center 1. Click on Grade Center from the Control Panel. 2. Click Full Grade Center from the expanded menu 3. Notice the third column of Last Access will list the last date each student lo

DocID: 1vgaT - View Document

History of Geo- and Space Sciences indexed in the Science Citation Index Expanded Thomson Reuters has announced that they will include the open access science-history journal History of Geo- and Space Sciences (HGSS) in

DocID: 1uOrB - View Document

Expanded Access to Investigational Drugs for Treatment Use — Questions and Answers Guidance for Industry

DocID: 1twh4 - View Document

fastacash, Cellum Take Aim At Trillion Dollar Mobile Payments Market  Jointly bring expanded, omni-channel service capabilities and access to new geographies and merchants, to take advantage of global mobile payments

DocID: 1sEfm - View Document

Expanded Access Navigator Public Workshop May 16, 2016 – 8:30am to 12:00pm FDA White Oak Campus, Building 31, Great RoomNew Hampshire Ave, Silver Spring, MDMeeting Objectives  Discuss the challenges fa

DocID: 1sywK - View Document